Viewing StudyNCT00523913



Ignite Creation Date: 2024-05-05 @ 6:40 PM
Last Modification Date: 2024-10-26 @ 9:35 AM
Study NCT ID: NCT00523913
Status: COMPLETED
Last Update Posted: 2016-10-28
First Post: 2007-08-31

Brief Title: A Study Of BRL49653C For The Treatment Of Type 2 Diabetes
Sponsor: GlaxoSmithKline
Organization: GlaxoSmithKline

Conditions & Keywords Data

Conditions:
Name
Diabetes Mellitus Type 2
Keywords:
Name View
Avandia View
type 2 diabetes mellitus View
diabetes View
rosiglitazone View